Jan-Steffen Krüssel

Prof. Dr. Jan-Steffen Krüssel

Ob/Gyn, Heinrich Heine University Düsseldorf, Düsseldorf, North Rhine-Westphalia, Germany

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2023 in Geburtshilfe und Frauenheilkunde
Verified
Journal Article
Open access
PDF file
VRVasilija Rolfes
Vasilija Rolfes
UBUta Bittner
Uta Bittner
HGHelene Gerhards
Helene Gerhards
JKJan-Steffen Krüssel
Jan-Steffen Krüssel
TFTanja Fehm
Tanja Fehm
HFHeiner Fangerau
Heiner Fangerau
Artificial intelligence is steadily being integrated into all areas of medicine. In reproductive medicine, artificial intelligence methods can be utilized to improve the selection and prediction of sperm cells, oocytes, and embryos and to generate better predictive models for in vitro fertilization. The use of artificial intelligence in this field is justified by the suffering of persons or couples who wish to have children but are unable to conceive. However, research into the use of artificial intelligence in reproductive medicine is still in the early experimental stage and furthermore raises complex normative questions. There are ethical research challenges because evidence of the efficacy of certain pertinent systems is often lacking and because of the increased difficulty of ensuring informed consent on the part of the affected persons. Other ethically relevant issues include the potential risks for offspring and the difficulty of providing sufficient information. The opportunity to fulfill the desire to have children affects the welfare of patients and their reproductive autonomy. Ultimately, ensuring more accurate predictions and allowing physicians to devote more time to their patients will have a positive effect. Nevertheless, clinicians must be able to process patient data conscientiously. When using artificial intelligence, numerous actors are involved in making the diagnosis and deciding on the appropriate therapy, raising questions about who is ultimately responsible when mistakes occur. Questions of fairness arise with regard to resource allocation and cost reimbursement. Thus, before implementing artificial intelligence in clinical practice, it is necessary to critically examine the quantity and quality of the data used and to address issues of transparency. In the medium and long term, it would be necessary to confront the undesirable impact and social dynamics that may accompany the use of artificial intelligence in reproductive medicine.

Verified
Journal Article
Open access
PDF file
ABAlexandra P Bielfeld
Alexandra P Bielfeld
SPSarah Jean Pour
Sarah Jean Pour
GPGereon Poschmann
Gereon Poschmann
KSKai Stühler
Kai Stühler
JKJan-Steffen Krüssel
Jan-Steffen Krüssel
DBDunja Maria Baston-Büst
Dunja Maria Baston-Büst
Background: The molecular signature of endometrial receptivity still remains barely understood, especially when focused on the possible benefit of therapeutical interventions and implantation-related pathologies. Therefore, the protein composition of tissue and isolated primary cells (endometrial stromal cells, ESCs) from endometrial scratchings of ART (Assisted Reproductive Techniques) patients with repeated implantation failure (RIF) was compared to volunteers with proven fertility during the time of embryo implantation (LH + 7). Furthermore, an analysis of the endometrial tissue of fertile women infused with human chorionic gonadotropin (hCG) was conducted. Methods: Endometrial samples (n = 6 RIF, n = 10 fertile controls) were split into 3 pieces: 1/3 each was frozen in liquid nitrogen, 1/3 fixed in PFA and 1/3 cultured. Protein lysates prepared from fresh frozen tissue were processed for mass spectrometric analysis. Results: Three proteins (EPPK1, BCLAF1 and PTMA) showed a statistically altered abundance in the endometrial tissue of RIF patients. Furthermore, pathways like metabolism, immune system, ferroptosis and the endoplasmic reticulum were altered in RIF patients. Remarkably, endometrial tissues of RIF patients showed a significantly higher (p-value = 9 × 10−8) protein intensity correlation (Pearson’s correlation coefficient = 0.95) compared to fertile women (Pearson’s correlation coefficient = 0.88). The in vivo infusion of hCG stimulated proteins of endocytosis, HIF1 signalling and chemokine production. Notably, patients suffering from RIF had a clinical pregnancy rate of 19% after the intrauterine infusion of hCG before embryo transfer (ET) compared to their failed previous cycles. Conclusion: Our study showed for the first time that the endometrial proteome composition of RIF patients differs from fertile controls during the window of implantation. The intrauterine infusion of hCG prior to an embryo transfer might improve the chemokine triggered embryo-endometrial dialogue and intensify the angiogenesis and immune response. From a clinical point of view, the hCG infusion prior to an embryo transfer might increase the pregnancy rate of RIF patients.

9 October 2018 in Geburtshilfe und Frauenheilkunde
Verified
Journal Article
Open access
PDF file
MBMatthias W. Beckmann
Matthias W. Beckmann
LLLaura Lotz
Laura Lotz
BTBettina Toth
Bettina Toth
DBDunja Maria Baston-Büst
Dunja Maria Baston-Büst
TFTanja Fehm
Tanja Fehm
RDRalf Dittrich
Ralf Dittrich
The cryopreservation of ovarian tissue with subsequent transplantation of the tissue represents an established method of fertility protection for female patients who have to undergo gonadotoxic therapy. The procedure can be performed at any point in the cycle and thus generally does not lead to any delay in oncological therapy. With the aid of this procedure, more than 130 births to date worldwide have been able to be recorded. The birth rate is currently approximately 30% and it can be assumed that this will increase through the further optimisation of the cryopreservation and surgical technique. The concept paper presented here is intended to provide guidance for managing cryopreservation and transplantation of ovarian tissue to German-speaking reproductive medicine centres. * Equal authorship

2 November 2010 in Reproductive Biology and Endocrinology
Verified
Journal Article
Open access
PDF file
DBDunja Maria Baston-Büst
Dunja Maria Baston-Büst
Martin GötteMartin Götte
Martin Götte
WJWolfgang Janni
Wolfgang Janni
JKJan-Steffen Krüssel
Jan-Steffen Krüssel
AHAlexandra P Hess
Alexandra P Hess
Successful embryonic implantation depends on a synchronized embryo-maternal dialogue. Chemokines, such as chemokine ligand 1 (CXCL1), play essential roles in the maternal reproductive tract leading to morphological changes during decidualization, mediating maternal acceptance towards the semi-allograft embryo and induction of angiogenesis. Chemokine binding to their classical G-protein coupled receptors is essentially supported by the syndecan (Sdc) family of heparan sulfate proteoglycans. The aim of this study was to identify the involvement of Sdc-1 at the embryo-maternal interface regarding changes of the chemokine and angiogenic profile of the decidua during the process of decidualization and implantation in human endometrium.

15 August 2013 in Cytokine
Verified
Journal Article
Closed access
DBDunja Maria Baston-Büst
Dunja Maria Baston-Büst
ASAndrea Schanz
Andrea Schanz
SBSarah Jean Böddeker
Sarah Jean Böddeker
OAOlga Altergot-Ahmad
Olga Altergot-Ahmad
JKJan-Steffen Krüssel
Jan-Steffen Krüssel
AHAlexandra Petra Hess
Alexandra Petra Hess

1 October 2020 in Reproductive BioMedicine Online
Verified
Journal Article
Open access
JJJulian Jenkins
Julian Jenkins
SPSheryl van der Poel
Sheryl van der Poel
JKJan-Steffen Krüssel
Jan-Steffen Krüssel
EBErnesto Bosch
Ernesto Bosch
SNScott M. Nelson
Scott M. Nelson
MYMylene M.W. Yao
Mylene M.W. Yao
The value of artificial intelligence to benefit infertile patients is a subject of debate. This paper presents the experience of one aspect of artificial intelligence, machine learning, coupled with patient empathy to improve utilization of assisted reproductive technology (ART), which is an important aspect of care that is under-recognized. Although ART provides very effective options for infertile patients to build families, patients often discontinue ART when further treatment is likely to be beneficial and most of these patients do not achieve pregnancy without medical aid. Use of ART is only in part dependent on financial considerations; stress and other factors play a major role, as shown by high discontinuation rates despite reimbursement. This commentary discusses challenges and strategies to providing personalized ART prognostics based on machine learning, and presents a case study where appropriate use of such prognostics in ART centres is associated with a trend towards increased ART utilization.